Follicle-Stimulating Hormone Glycobiology.
Bousfield GR, Harvey DJ.
Endocrinology. 2019 Jun 1;160(6):1515-1535. doi: 10.1210/en.2019-00001.
Hormone receptors.
Baxter JD, Funder JW.
N Engl J Med. 1979 Nov 22;301(21):1149-61. doi: 10.1056/NEJM197911223012104.
Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer (11)C-TASP699.
Naganawa M, Nabulsi NB, Matuskey D, Henry S, Ropchan J, Lin SF, Gao H, Pracitto R, Labaree D, Zhang MR, Suhara T, Nishino I, Sabia H, Ozaki S, Huang Y, Carson RE.
J Nucl Med. 2022 Apr;63(4):609-614. doi: 10.2967/jnumed.121.262430. Epub 2021 Aug 12.
Positron emission tomography measurement of dopamine D2 receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Arakawa R, Okumura M, Ito H, Takano A, Takahashi H, Takano H, Maeda J, Okubo Y, Suhara T.
J Clin Psychiatry. 2010 Sep;71(9):1131-7. doi: 10.4088/JCP.08m04307yel. Epub 2010 Feb 23.
Ketoconazole-associated preferential increase in dopamine D2 receptor occupancy in striatum compared to pituitary in vivo: role for drug transporters?
Reist C, Wu JC, Lilja Y, Mukherjee J, Gripeos D, Constantinescu C, Raggi MA, Mercolini L, Ozdemir V.
J Clin Psychopharmacol. 2012 Feb;32(1):110-3. doi: 10.1097/JCP.0b013e3182408fc8.
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist.
Robberecht P, Gourlet P, De Neef P, Woussen-Colle MC, Vandermeers-Piret MC, Vandermeers A, Christophe J.
Eur J Biochem. 1992 Jul 1;207(1):239-46. doi: 10.1111/j.1432-1033.1992.tb17043.x.
The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis.
Jacobson L, Sapolsky R.
Endocr Rev. 1991 May;12(2):118-34. doi: 10.1210/edrv-12-2-118.
Prolactin Elevations and Permeability Glycoprotein.
El-Mallakh RS, Watkins J.
Prim Care Companion CNS Disord. 2019 May 16;21(3):18nr02412. doi: 10.4088/PCC.18nr02412.
Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system.
Aguilera G, Wynn PC, Harwood JP, Hauger RL, Millan MA, Grewe C, Catt KJ.
Neuroendocrinology. 1986;43(1):79-88. doi: 10.1159/000124513.
Relationship between the accumulation of pituitary growth hormone and nuclear occupancy by triiodothyronine in the rat.
Coulombe P, Schwartz HL, Oppenheimer JH.
J Clin Invest. 1978 Nov;62(5):1020-8. doi: 10.1172/JCI109206.
